University of Minnesota receives seed funding for clinical study of metformin to treat, prevent COVID-19
(University of Minnesota Medical School) University of Minnesota Medical School researchers received funding from the Parsemus Foundation to initiate research on the widely-used diabetes medication, metformin, available globally as an inexpensive generic drug for prevention and treatment for COVID-19.
Source: EurekAlert! - Medicine and Health - Category: International Medicine & Public Health Source Type: news
More News: COVID-19 | Diabetes | Endocrinology | Fortamet | Funding | International Medicine & Public Health | Metformin | Study | University of Minnesota